Hospital
Bronson South Haven Hospital
Bronson South Haven Hospital was paid $10.85M by Medicaid between Jan 2018 and Dec 2024, across 191 billing codes. Its largest line is 99283, emergency room visit (moderate) — 23% of everything it billed.
33Billing provider infoBRONSON SOUTH HAVEN HOSPITAL
SOUTH HAVEN, MI 49090
SOUTH HAVEN, MI 49090
33aNPI1346275856assigned 07/12/2006
33bProvider typeMedicare Defined Swing Bed Hospital Unit
28Total paid$10.85M
24GClaims365,651
24DCodes billed191
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Medicare Defined Swing Bed Hospital Unit providers in Michigan
Rank by total paid#2 of 8
Median peer was paid$5.78M
This provider vs. median1.9×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official EAST, REBECCA controls 14+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 47,236 | $1.22M | |
| 2019 | 43,238 | $1.17M | |
| 2020 | 40,627 | $1.12M | |
| 2021 | 56,031 | $1.69M | |
| 2022 | 58,967 | $1.91M | |
| 2023 | 64,092 | $2.04M | |
| 2024incomplete | 55,460 | $1.71M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 23% | 19,881 | 18,791 | $2.47M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 18% | 9,022 | 8,437 | $1.98M |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.0% | 10,547 | 10,213 | $762K |
| 97110 | Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion | 6.6% | 24,743 | 6,706 | $717K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 6.5% | 2,025 | 1,935 | $704K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 6.1% | 6,594 | 6,138 | $664K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.9% | 1,919 | 1,891 | $314K |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | 2.8% | 3,527 | 3,465 | $307K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 1.9% | 2,097 | 1,598 | $203K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | 1.7% | 425 | 418 | $186K |
| 96361 | Intravenous infusion, hydration; each additional hour | 1.6% | 5,721 | 5,141 | $174K |
| 96375 | Therapeutic injection; each additional sequential IV push | 1.5% | 4,956 | 4,603 | $167K |
179 more codes
| 71046 | Radiologic examination, chest; 2 views | 1.3% | 3,510 | $136K |
| 71045 | Radiologic examination, chest; single view | 1.2% | 3,069 | $127K |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 1,027 | $107K |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 1,404 | $105K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 1,973 | $100K |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 1,314 | $87K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 2,022 | $80K |
| 97140 | Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) | <1% | 6,452 | $79K |
| 97161 | <1% | 1,571 | $75K | |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 1,565 | $74K |
| 80061 | Lipid panel | <1% | 6,727 | $69K |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 1,123 | $63K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 4,162 | $59K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 4,161 | $59K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 937 | $58K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 7,769 | $55K |
| 36415 | Collection of venous blood by venipuncture | <1% | 25,345 | $51K |
| 86900 | <1% | 1,497 | $49K | |
| 76801 | <1% | 800 | $48K | |
| 80053 | Comprehensive metabolic panel | <1% | 18,859 | $46K |
| 76830 | Ultrasound, transvaginal | <1% | 743 | $44K |
| 97162 | <1% | 925 | $43K | |
| 87661 | Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe | <1% | 3,531 | $41K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 1,138 | $32K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 22,300 | $31K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 264 | $31K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 2,067 | $28K |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 5,285 | $25K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 6,614 | $23K |
| 97112 | Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination | <1% | 1,303 | $23K |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 2,651 | $22K |
| 97597 | <1% | 200 | $17K | |
| 97530 | Therapeutic activities, direct patient contact, each 15 minutes | <1% | 865 | $17K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 112 | $14K |
| G0145 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, with screening by automated system and manual rescreening under physician supervision | <1% | 909 | $14K |
| 86780 | <1% | 1,705 | $13K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 4,269 | $11K |
| 85027 | <1% | 3,544 | $10K | |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 703 | $10K |
| 82607 | <1% | 1,291 | $9K | |
| 97035 | <1% | 1,553 | $8K | |
| G0378 | Hospital observation service, per hour | <1% | 32 | $8K |
| 84702 | <1% | 1,770 | $8K | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 2,003 | $8K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 30 | $8K |
| 86803 | <1% | 1,430 | $7K | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 4,250 | $7K |
| 82728 | <1% | 1,072 | $7K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 537 | $7K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | <1% | 324 | $6K |
| 73630 | <1% | 847 | $6K | |
| 83655 | <1% | 847 | $6K | |
| 81025 | <1% | 5,288 | $6K | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 5,286 | $6K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 564 | $6K |
| 74018 | <1% | 295 | $5K | |
| 84466 | <1% | 872 | $5K | |
| 72100 | <1% | 173 | $5K | |
| 84439 | <1% | 1,284 | $5K | |
| 87631 | <1% | 423 | $5K | |
| 20610 | <1% | 27 | $5K | |
| 73562 | <1% | 351 | $4K | |
| 73030 | <1% | 286 | $4K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 472 | $4K |
| 83540 | <1% | 1,238 | $4K | |
| 87077 | <1% | 1,853 | $4K | |
| 87340 | <1% | 1,350 | $3K | |
| 81001 | <1% | 10,419 | $3K | |
| 73610 | <1% | 596 | $3K | |
| 85610 | <1% | 2,460 | $3K | |
| 87186 | <1% | 1,513 | $3K | |
| 86140 | <1% | 1,847 | $3K | |
| 83735 | <1% | 1,895 | $2K | |
| 82570 | <1% | 884 | $2K | |
| 87150 | <1% | 122 | $2K | |
| 82950 | <1% | 761 | $2K | |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 17 | $2K |
| 0011A | <1% | 56 | $2K | |
| 81003 | <1% | 3,254 | $2K | |
| 73130 | <1% | 365 | $2K | |
| 0012A | <1% | 50 | $2K | |
| 97165 | <1% | 37 | $2K | |
| 93975 | <1% | 13 | $2K | |
| 82043 | <1% | 599 | $2K | |
| 83516 | <1% | 215 | $1K | |
| 82746 | <1% | 229 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 43 | $1K |
| 83880 | <1% | 364 | $1K | |
| 84481 | <1% | 188 | $1K | |
| 85652 | <1% | 1,484 | $1K | |
| 86376 | <1% | 227 | $1K | |
| 73110 | <1% | 172 | $1K | |
| 87081 | <1% | 311 | $1K | |
| 76642 | <1% | 25 | $1K | |
| 96367 | <1% | 25 | $962.78 | |
| 87070 | <1% | 316 | $947.68 | |
| 83690 | <1% | 4,401 | $906.84 | |
| 85018 | <1% | 731 | $874.24 | |
| 86038 | <1% | 151 | $745.90 | |
| 87220 | <1% | 898 | $677.32 | |
| 77080 | <1% | 12 | $656.04 | |
| 0071A | <1% | 28 | $643.45 | |
| 76770 | <1% | 12 | $638.91 | |
| 0072A | <1% | 23 | $625.10 | |
| 90686 | <1% | 33 | $617.02 | |
| 85730 | <1% | 962 | $614.59 | |
| 0001A | <1% | 17 | $591.55 | |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | <1% | 669 | $586.67 |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | <1% | 125 | $570.52 |
| 86850 | <1% | 1,276 | $507.09 | |
| 93017 | <1% | 24 | $506.60 | |
| 0002A | <1% | 13 | $454.20 | |
| 80306 | <1% | 133 | $442.64 | |
| 80076 | <1% | 159 | $435.32 | |
| 94726 | <1% | 12 | $426.73 | |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 37 | $410.46 |
| 0064A | <1% | 14 | $402.30 | |
| 73140 | <1% | 53 | $356.54 | |
| 0124A | <1% | 14 | $296.19 | |
| 87205 | <1% | 163 | $294.48 | |
| 86800 | <1% | 40 | $227.28 | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 16 | $173.08 |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 15 | $127.34 |
| 86200 | <1% | 26 | $110.92 | |
| 84403 | <1% | 14 | $109.99 | |
| 83605 | <1% | 1,874 | $104.24 | |
| 84484 | <1% | 4,024 | $102.59 | |
| 73502 | <1% | 13 | $96.66 | |
| 97014 | <1% | 30 | $95.92 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 2,054 | $93.89 |
| 85380 | <1% | 563 | $93.55 | |
| 84703 | <1% | 286 | $81.50 | |
| 82565 | <1% | 28 | $68.96 | |
| 87040 | <1% | 436 | $60.92 | |
| 81002 | <1% | 31 | $53.70 | |
| 80143 | <1% | 181 | $40.91 | |
| 90715 | <1% | 392 | $38.38 | |
| 82550 | <1% | 26 | $38.10 | |
| J2272 | Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg | <1% | 13 | $37.43 |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 6,330 | $32.24 |
| 80179 | <1% | 140 | $29.82 | |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 3,772 | $19.64 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 5,998 | $17.25 |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | <1% | 1,569 | $16.78 |
| 86901 | <1% | 1,582 | $16.28 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 806 | $9.27 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 760 | $7.25 |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 1,240 | $7.14 |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,011 | $6.70 |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,334 | $5.08 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 0% | 469 | $0.00 |
| 96376 | 0% | 962 | $0.00 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | 0% | 381 | $0.00 |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | 0% | 224 | $0.00 |
| J2704 | Injection, propofol, 10 mg | 0% | 395 | $0.00 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | 0% | 768 | $0.00 |
| 0064U | 0% | 97 | $0.00 | |
| J2060 | Injection, lorazepam, 2 mg | 0% | 49 | $0.00 |
| J1010 | Injection, methylprednisolone acetate, 1 mg | 0% | 101 | $0.00 |
| J1630 | Injection, haloperidol, up to 5 mg | 0% | 14 | $0.00 |
| J7050 | Infusion, normal saline solution, 250 cc | 0% | 18 | $0.00 |
| P9603 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated miles actually travelled | 0% | 31 | $0.00 |
| J2003 | Injection, lidocaine hydrochloride, 1 mg | 0% | 14 | $0.00 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 71 | $0.00 |
| 97750 | 0% | 46 | $0.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | 0% | 14 | $0.00 |
| 12001 | 0% | 14 | $0.00 | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | 0% | 4,401 | $0.00 |
| J0780 | Injection, prochlorperazine, up to 10 mg | 0% | 25 | $0.00 |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | 0% | 932 | $0.00 |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | 0% | 1,552 | $0.00 |
| G8978 | Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals | 0% | 14 | $0.00 |
| J2550 | Injection, promethazine hcl, up to 50 mg | 0% | 168 | $0.00 |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | 0% | 106 | $0.00 |
| 94729 | 0% | 12 | $0.00 | |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 19 | $0.00 |
| 84145 | 0% | 55 | $0.00 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | 0% | 14 | $0.00 |
| G8979 | Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialEAST, REBECCA (SVP, CFO)
| Provider | Location | Paid |
|---|---|---|
| Bronson Methodist Hospital | Kalamazoo, MI | $109.07M |
| Bronson Methodist Hospital | Kalamazoo, MI | $64.91M |
| Bronson Battle Creek Hospital | Battle Creek, MI | $43.89M |
| Bronson Lakeview Hospital | Paw Paw, MI | $15.63M |
| Bronson Battle Creek Hospital | Battle Creek, MI | $9.80M |
| Bronson Lakeview Hospital | Paw Paw, MI | $6.57M |
| Bronson South Haven Hospital | South Haven, MI | $3.92M |
| Bronson at Home | Battle Creek, MI | $2.96M |
| Bronson Methodist Hospital | Kalamazoo, MI | $1.93M |
| Bronson South Haven Hospital | South Haven, MI | $704K |
| Bronson Lakeview Hospital | Decatur, MI | $563K |
| Bronson Lakeview Hospital | Bangor, MI | $530K |
| Bronson Lakeview Hospital | South Haven, MI | $134K |
| Bronson Lakeview Hospital | Paw Paw, MI | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.